Asia Pacific Medical Technology Association (APACMed)

𝗨𝗽𝗰𝗼𝗺𝗶𝗻𝗴 𝗘𝘃𝗲𝗻𝘁𝘀 𝗶𝗻 𝗔𝗽𝗿𝗶𝗹! We are excited to share our events for the month. Check out the full calendar for details: https://lnkd.in/gEJMFmY4

𝗔𝗕𝗖 𝗖𝗵𝗶𝗻𝗮: 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝗽𝗮𝘁𝗵𝘄𝗮𝘆𝘀 𝗼𝗳 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗖𝗵𝗶𝗻𝗮 On 26 March, MedTech experts at the APACMed Breakfast Conversation series in China explored clinical innovation pathways through enhanced partnership between hospitals and the industry. We were honoured to have Dr. Wu Guanghui, Director of Technology Transfer at Anzhen Hospital, provide insights on how Anzhen Hospital fosters clinical innovation through talent development, strategic funding, and the establishment of a robust innovation platform. A dynamic panel discussion followed, where our panelists dived into the topic of multi-stakeholder collaboration in clinical innovation. They shared international case studies, highlighted the critical role of proof-of-concept platforms, and examined the impact of reimbursement policies. Additionally, they discussed multiple payment models for innovative medical products, and strategies for effective market positioning to drive commercialisation. APACMed China will continue to support clinical innovation together with our partners and members to explore unmet medical needs and the potential of innovation. APACMed China Secretariat: Alicia Chang Zoey Ma

Our appreciation to everyone who joined our AI Regulations and Landscape in APAC webinar. We explored the evolving regulatory frameworks across the region and dived into key markets with notable developments. A special appreciation to Katherine Wang, Partner at Ropes & Gray LLP, for her in-depth insights on the regulatory landscape and what to anticipate in 2025. Missed the session? Watch the full recording here: https://lnkd.in/gPMAEmt5 Stay connected with APACMed’s AI Working Group for more discussions and updates on AI in MedTech! APACMed Secretariat: Su Fen Ong, Devya B.

𝗖𝗵𝗶𝗻𝗮’𝘀 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝗻𝗱 𝗔𝗜 𝗣𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 Join us on 3 April for the webinar where we will unpack the priorities highlighted in the recently released China's 2025 Government Work Report on healthcare for your business and explore digital health and AI trends in China’s medical device market. Our speakers: • Ms Tina Liu, Partner,AllBright Law Offices • Ms Guan Ziyan, CAICT • Ms Shweta Bhardwaj, (MSc, MBA), Director, Global R&D & Digital Policy, Worldwide Govt. Affairs & Policy (WWGA&P), Johnson & Johnson • Mr Tony Yao, Head of Digital Product Delivery, Roche Diagnostics China • Mr Jim Lim Shien Min, PMP, Head of Health Ecosystem APAC, Zühlke Group Register now to gain crucial insights for your business: https://lnkd.in/guc9HqTd Exclusively for APACMed members. APACMed Contacts: Alicia Chang, Su Fen Ong

𝗔𝗜 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲: 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗖𝗮𝗿𝗲 Cardiovascular disease remains a major health concern, claiming countless lives. But there's hope on the horizon. AI-powered medical solutions are transforming patient care, with the ability to predict heart failure in a shorter amount of time. Our latest research explores how collaborative AI-enabled MedTech innovations are improving clinical outcomes across APAC. https://lnkd.in/efiD45ar #APACMed #APACMedxKPMG #APACMedxAI #MedTech #AIinMedTech #HealthcareInnovation #ResponsibleAI

𝗖𝗮𝗹𝗹𝗶𝗻𝗴 𝗔𝗹𝗹 #𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀 – 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗼𝗻 𝗲𝗤𝗠𝗦 𝗳𝗼𝗿 𝗦𝗰𝗮𝗹𝗮𝗯𝗹𝗲 𝗚𝗿𝗼𝘄𝘁𝗵 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 For MedTech start-ups, long-term success relies on early investment in quality, compliance, and scalability. Beyond regulatory requirements, investors seek robust processes, operational excellence, and a clear path to sustainable growth. An electronic Quality Management System (eQMS) can be key to achieving these goals. You are invited to an exclusive in-person workshop on 𝟯𝗿𝗱 𝗔𝗽𝗿𝗶𝗹, 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆, to discover how an eQMS can be a game-changer for a MedTech company’s growth and compliance. 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀 • Tamir Podhurst, Co-Founder, Simploud • Melvin You, Compliance Solutions Director, QualityScape • Haryani Zainol, Manager QARA, AMT 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 • 𝗘𝘅𝗽𝗲𝗿𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: Understand how an eQMS can streamline processes, boost efficiency and reduce risks. • 𝗟𝗶𝘃𝗲 𝗗𝗲𝗺𝗼: Learn how Simploud manages controlled documents, training records, change controls, quality events, supplier audits, and more. • 𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝗦𝘁𝗼𝗿𝗶𝗲𝘀: Hear from a MedTech company that successfully implemented Simploud. • 𝗙𝗶𝗿𝗲𝘀𝗶𝗱𝗲 𝗖𝗵𝗮𝘁: Discover how eQMS strengthens controls and cuts compliance burdens. ☑️ 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗬𝗼𝘂𝗿 𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁 𝗡𝗼𝘄: https://lnkd.in/gZHAHqwN 𝗙𝗲𝗲𝘀 APACMed Members: Complimentary Non-Members: US$100

Our big thanks to everyone who joined our “Understanding APAC’s Laboratory Developed Tests (LDT) Regulations – A Strategic Outlook for Healthcare” webinar. Special appreciation to Katherine Wang, Chrissy Huang, Yasha Huang (CPCC, MPH, MA), and Charles Lim Chee Hong for their in-depth insights on the topic. Stay connected with APACMed’s RA LDT Project for more discussions and updates! Missed the session? Watch the full recording here: https://lnkd.in/g-TAFexg APACMed Secretariat: Cindy Pelou, Devya B.

𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝗔𝗜 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗠𝗲𝗱𝗧𝗲𝗰𝗵: 𝗪𝗵𝗮𝘁 𝘁𝗼 𝗘𝘅𝗽𝗲𝗰𝘁 𝗶𝗻 𝟮𝟬𝟮𝟱 As AI adoption in MedTech accelerates, evolving regulatory frameworks are shaping the industry’s future across APAC. Join us for a timely webinar featuring Katherine Wang, Partner at Ropes & Gray LLP, who will provide insights on the latest regulatory developments in AI and the anticipated developments in 2025. 𝗪𝗵𝗮𝘁 𝘄𝗲 𝘄𝗶𝗹𝗹 𝗰𝗼𝘃𝗲𝗿: • Key regulatory trends and developments in AI for MedTech across APAC • How regulatory frameworks are evolving and what to anticipate in 2025 • Opportunities for cross-border collaboration and harmonisation of AI regulations 𝗠𝗮𝗿𝗸𝗲𝘁𝘀 𝗶𝗻 𝗳𝗼𝗰𝘂𝘀: 🇦🇺 Australia | 🇨🇳 China | 🇯🇵 Japan | 🇰🇷 Korea Don't miss this opportunity to stay ahead of AI regulatory changes that could impact your business strategy. 📍𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄: https://lnkd.in/gr6KTUba 📅 𝗗𝗮𝘁𝗲: 26 March 2025 🕰️ 𝗧𝗶𝗺𝗲: 3PM SGT 𝘌𝘹𝘤𝘭𝘶𝘴𝘪𝘷𝘦𝘭𝘺 𝘧𝘰𝘳 𝘈𝘗𝘈𝘊𝘔𝘦𝘥 𝘮𝘦𝘮𝘣𝘦𝘳𝘴. [APACMed Contact: Su Fen Ong]

𝗖𝗵𝗶𝗻𝗮’𝘀 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝗻𝗱 𝗔𝗜 𝗣𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗶𝗻 𝟮𝟬𝟮𝟱 Join us on 3 April 2025 for an APACMed webinar, organised by our China office, where we unpack the recently released China’s 2025 𝘎𝘰𝘷𝘦𝘳𝘯𝘮𝘦𝘯𝘵 𝘞𝘰𝘳𝘬 𝘙𝘦𝘱𝘰𝘳𝘵 on healthcare, explore their impact on business, and discuss digital health and AI trends in China’s medical device market. Our speakers: • Ms Tina Liu, Partner, AllBright Law Offices • Ms Guan Ziyan, CAICT • Ms Shweta Bhardwaj, (MSc, MBA), Director, Global R&D & Digital Policy, Worldwide Govt. Affairs & Policy (WWGA&P), Johnson & Johnson • Mr Tony Yao, Head of Digital Product Delivery, Roche Diagnostics China • Mr Jim Lim, Head of Health Ecosystem APAC, Zühlke Group Register now to gain crucial insights for your business: https://lnkd.in/guc9HqTd Exclusively for APACMed members. APACMed Contacts: Alicia Chang, Su Fen Ong

Thank you, #APACMed community, for joining us at our Annual General Meeting and Townhall yesterday. Your ongoing support and our shared mission to expand patient access to innovative medical technology in APAC will empower us to create a lasting impact in 2025 and beyond. 🦾 You can now access our 2024 Annual Report here: https://lnkd.in/gM2rBW_F #WeAreTheVoiceOfMedTech #APAC